Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences Revenue

In the year 2024, Cytek Biosciences had annual revenue of $200.45M with 3.85% growth. Cytek Biosciences had revenue of $57.48M in the quarter ending December 31, 2024, a decrease of -1.30%.

• Revenue (ttm): $200.45M
• Revenue Growth: +3.85%
• P/S Ratio: 2.46
• Revenue / Employee: $309,341
• Employees: 648
• Market Cap: 482.93M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	200.45M	7.44M	3.85%
Dec 31, 2023	193.02M	28.98M	17.67%
Dec 31, 2022	164.04M	36.09M	28.20%
Dec 31, 2021	127.95M	35.11M	37.82%
Dec 31, 2020	92.84M	34.96M	60.39%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.